Venture Life Group Plc

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BFPM8908
GBP
0.61
0.01 (0.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Venture Life Group Plc stock-summary
stock-summary
Venture Life Group Plc
Pharmaceuticals & Biotechnology
Venture Life Group plc is an international consumer self-care company. The Company focuses on developing, manufacturing and commercializing products for the ageing population. Its segments include Brands, which includes sales of branded healthcare and cosmetics products direct to retailers and under distribution agreements, and Manufacturing, which includes sales of products and services under contract development and manufacturing agreements. Its product range includes the UltraDEX and Dentyl oral care range, which is primarily sold in the United Kingdom through the pharmacy and grocery retailers. Its product range also includes food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing and medical devices for conditions, such as hemorrhoids, minor aches and pains, and women's intimate health issues. It also provides development and manufacturing services to other companies in the healthcare and skincare sectors.
Company Coordinates stock-summary
Company Details
Unit 12, The Courtyard, Eastern Road , BRACKNELL None : RG12 2XB
stock-summary
Tel: 44 1344 578004
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Lynn Drummond
Non-Executive Chairman of the Board
Jerry Randall
Chief Executive Officer, Executive Director
Gianluca Braguti
Executive Director, Manufacturing Director
Sharon Collins
Executive Director, Commercial Director
Mr. Peter Bream
Non-Executive Director
Mr. Carl Dempsey
Non-Executive Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 77 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.28

stock-summary
Return on Equity

-3.34%

stock-summary
Price to Book

1.03